Seeking Alpha

Biotechtrader8

Biotechtrader8
Send Message
View as an RSS Feed
View Biotechtrader8's Comments BY TICKER:
Latest  |  Highest rated
  • MacroGenics - Good Pipeline, Stretched Valuation [View article]
    What are your thoughts nearly a year later? I was in MGNX from their 52 week low around ~17 up to mid 20s and took some gains. Then it really took off, to my dismay. Now post Janssen deal we see it settle. Ph2 MGAH22 soon, and Ph3 looming. I am curious how your view has changed nearly a year later. I think the company definitely has some momentum but I would like to see a bit more of a pullback before entering.
    Jan 12, 2015. 11:11 PM | Likes Like |Link to Comment
  • Amarin Corp: An Oversold Investment Opportunity [View article]
    what model did you use for the $1.90/share without reduce-it potential? multiple of yr13 revenue?
    Oct 23, 2013. 06:15 PM | Likes Like |Link to Comment
  • Amarin Corp: An Oversold Investment Opportunity [View article]
    what kind of model did you use to determine $1.9/share current value without presumed future reduce-it potential?
    Oct 23, 2013. 06:15 PM | Likes Like |Link to Comment
  • The Latest On Amarin - How Will The Investment Pay Off? [View article]
    Wasn't there some comment in the CC regarding word that Amarin has recieved notice of a letter being drafted by FDA but with no knowledge of its content? Wouldn't this imply a probable/hopeful decision to be made by this upcoming friday orange book date?
    Nov 13, 2012. 01:19 PM | 2 Likes Like |Link to Comment
  • Led By Vibex MTX, Antares' Pipeline Is Bursting With New Products [View article]
    *Another possible catalyst..... Pfizer product disclosure
    Sep 13, 2012. 05:46 PM | Likes Like |Link to Comment
  • Led By Vibex MTX, Antares' Pipeline Is Bursting With New Products [View article]
    Any idea of what kind of pps we might see post Vibex clinical trial news in october or vibex NDA being filed Q4'12-Q1'13?
    Sep 13, 2012. 10:45 AM | Likes Like |Link to Comment
COMMENTS STATS
6 Comments
2 Likes